Primary Site >> Colorectal Cancer

Gene >> ABCC1

  • 1993
  • 1995
  • 1996
  • 1997
  • 1998
  • 1999
  • 2000
  • 2001
  • 2002
  • 2003
  • 2004
  • 2005
  • 2006
  • 2007
  • 2008
  • 2009
  • 2010
  • 2011
  • 2012
  • 2013
  • 2014
  • 2015
  • 2016
  • 2017
  • 2018
Ref: Heterogeneity of mucin gene expression in normal and neoplastic tissues.
PMID: 7678777
Ref: The LRP gene encoding a major vault protein associated with drug resistance maps proximal to MRP on chromosome 16: evidence that chromosome breakage plays a key role in MRP or LRP gene amplification.
PMID: 7671223
Ref: Effects of chronic ethacrynic acid exposure on glutathione conjugation and MRP expression in human colon tumor cells.
PMID: 8630053
Ref: Frequent coordinated overexpression of the MRP/GS-X pump and gamma-glutamylcysteine synthetase genes in human colorectal cancers.
PMID: 8705999
Ref: Tumor necrosis factor-alpha and expression of the multidrug resistance-associated genes LRP and MRP.
PMID: 9182980
Ref: Human canalicular multispecific organic anion transporter (cMOAT) is expressed in human lung, gastric, and colorectal cancer cells.
PMID: 9398612
Ref: Frequent coexpression of MRP/GS-X pump and gamma-glutamylcysteine synthetase mRNA in drug-resistant cells, untreated tumor cells, and normal mouse tissues.
PMID: 9515571
Ref: Reversal of a novel multidrug resistance mechanism in human colon carcinoma cells by fumitremorgin C.
PMID: 9865745
Ref: Expression of multidrug resistance protein in metastatic colorectal carcinomas.
PMID: 10535485
Ref: [Mechanisms for resistance to anticancer agents and the reversal of the resistance].
PMID: 10695015
Ref: [Expression of multidrug resistance-associated protein (MRP) and lung resistance protein (LRP) in human rectal carcinomas and its clinical significance].
PMID: 11776833
Ref: Discovery and characterization of OC144-093, a novel inhibitor of P-glycoprotein-mediated multidrug resistance.
PMID: 10850444
Ref: Differential expression of sphingolipids in MRP1 overexpressing HT29 cells.
PMID: 10861470
Ref: Increased expression of an ATP-binding cassette superfamily transporter, multidrug resistance protein 2, in human colorectal carcinomas.
PMID: 10873092
Ref: New highly lipophilic camptothecin BNP1350 is an effective drug in experimental human cancer.
PMID: 11004678
Ref: Induction of MRP1 and gamma-glutamylcysteine synthetase gene expression by interleukin 1beta is mediated by nitric oxide-related signalings in human colorectal cancer cells.
PMID: 11025451
Ref: The human multidrug resistance-associated protein (MRP) gene family: from biological function to drug molecular design.
PMID: 11097346
Ref: Alkali-catalyzed beta-elimination of periodate-oxidized glycans: a novel method of chemical deglycosylation of mucin gene products in paraffin embedded sections.
PMID: 11425189
Ref: Reversal of LRP-associated drug resistance in colon carcinoma SW-620 cells.
PMID: 11149411
Ref: Differential sensitivities of the MRP gene family and gamma-glutamylcysteine synthetase to prooxidants in human colorectal carcinoma cell lines with different p53 status.
PMID: 11239498
Ref: Hyperthermia-induced nuclear translocation of transcription factor YB-1 leads to enhanced expression of multidrug resistance-related ABC transporters.
PMID: 11369762
Ref: Reversal of cisplatin and multidrug resistance by ribozyme-mediated glutathione suppression.
PMID: 11500053
Ref: Long-term cultivation of colorectal carcinoma cells with anti-cancer drugs induces drug resistance and telomere elongation: an in vitro study.
PMID: 11518543
Ref: Characterization of a human colorectal carcinoma cell line with acquired resistance to flavopiridol.
PMID: 11641415
Ref: Induction of multidrug resistance proteins MRP1 and MRP3 and gamma-glutamylcysteine synthetase gene expression by nonsteroidal anti-inflammatory drugs in human colon cancer cells.
PMID: 11820781
Ref: Intestinal transport of irinotecan in Caco-2 cells and MDCK II cells overexpressing efflux transporters Pgp, cMOAT, and MRP1.
PMID: 12065434
Ref: Gene expression of CYP3A4, ABC-transporters (MDR1 and MRP1-MRP5) and hPXR in three different human colon carcinoma cell lines.
PMID: 12625868
Ref: Gene expression profiles of ABC transporters and cytochrome P450 3A in Caco-2 and human colorectal cancer cell lines.
PMID: 12636175
Ref: Glucuronidation as a mechanism of intrinsic drug resistance in colon cancer cells: contribution of drug transport proteins.
PMID: 14667926
Ref: MRP1 and glucosylceramide are coordinately over expressed and enriched in rafts during multidrug resistance acquisition in colon cancer cells.
PMID: 15122583
Ref: Cyclooxygenase-2 gene induction causes CDDP resistance in colon cancer cell line, HCT-15.
PMID: 15517878
Ref: Efflux of depsipeptide FK228 (FR901228, NSC-630176) is mediated by P-glycoprotein and multidrug resistance-associated protein 1.
PMID: 15634944
Ref: Clinical pharmacokinetics of irinotecan-based chemotherapy in colorectal cancer patients.
PMID: 18666754
Ref: Correlation of induction of ATP binding cassette transporter A5 (ABCA5) and ABCB1 mRNAs with differentiation state of human colon tumor.
PMID: 17541169
Ref: Transcriptional recapitulation and subversion of embryonic colon development by mouse colon tumor models and human colon cancer.
PMID: 17615082
Ref: Functional evaluation of multidrug resistance transporter activity in surgical samples of solid tumors.
PMID: 17767422
Ref: A novel method to quantify sphingosine 1-phosphate by immobilized metal affinity chromatography (IMAC).
PMID: 17991617
Ref: Effect of pO2 on antitumor drug cytotoxicity on MDR and non-MDR variants selected from the LoVo metastatic colon carcinoma cell line.
PMID: 18383825
Ref: Fractionated irradiation can induce functionally relevant multidrug resistance gene and protein expression in human tumor cell lines.
PMID: 18582150
Ref: Folate deprivation induces BCRP (ABCG2) expression and mitoxantrone resistance in Caco-2 cells.
PMID: 18623116
Ref: Celecoxib upregulates multidrug resistance proteins in colon cancer: lack of synergy with standard chemotherapy.
PMID: 18690847
Ref: Cellular folate status modulates the expression of BCRP and MRP multidrug transporters in cancer cell lines from different origins.
PMID: 19240161
Ref: Identification of a novel topoisomerase inhibitor effective in cells overexpressing drug efflux transporters.
PMID: 19798419
Ref: Drug efflux transporters, MRP1 and BCRP, affect the outcome of hypericin-mediated photodynamic therapy in HT-29 adenocarcinoma cells.
PMID: 20024169
Ref: Expression of HSP27, HSP72 and MRP proteins in in vitro co-culture of colon tumour cell spheroids with normal cells after incubation with rhTGF- beta1 and/or CPT-11.
PMID: 20093746
Ref: Molecular determinants of folate levels after leucovorin administration in colorectal cancer.
PMID: 19636555
Ref: Effects of dietary ingredients on function and expression of P-glycoprotein in human intestinal epithelial cells.
PMID: 20118549
Ref: Hepatocyte growth factor (HGF), heat shock proteins (HSPs) and multidrug resistance protein (MRP) expression in co-culture of colon tumor spheroids with normal cells after incubation with interleukin-1beta (IL-1beta) and/or camptothecin (CPT-11).
PMID: 20726333
Ref: [Effects of changwelqing on nuclear translocation of Y-box binding protein-1 and expression of P-glycoprotein in human colon cancer cell line with drug-resistance induced by vincristine].
PMID: 20929136
Ref: [Effect and mechanism of DNMT inhibitor on the reversal of multidrug resistance in human colon cancer cell line sw620/L-OHP].
PMID: 21265097
Ref: Novel acrylonitrile derivatives, YHO-13177 and YHO-13351, reverse BCRP/ABCG2-mediated drug resistance in vitro and in vivo.
PMID: 21566063
Ref: Modulation of doxorubicin resistance by the glucose-6-phosphate dehydrogenase activity.
PMID: 21679161
Ref: Multidrug-resistance proteins are weak tumor associated antigens for colorectal carcinoma.
PMID: 21740599
Ref: The role of paclitaxel in the development and treatment of multidrug resistant cancer cell lines.
PMID: 21775090
Ref: [The effect of small GTPase Cdc42 on the multidrug resistance of oxaliplatin-resistant colon cancer cell lines].
PMID: 21866627
Ref: MC70 potentiates doxorubicin efficacy in colon and breast cancer in vitro treatment.
PMID: 21925160
Ref: A combined experimental and mathematical approach for molecular-based optimization of irinotecan circadian delivery.
PMID: 21931543
Ref: Methylenetetrahydrofolate reductase genetic polymorphisms and toxicity to 5-FU-based chemoradiation in rectal cancer.
PMID: 22045187
Ref: The role of ABC transporters in progression and clinical outcome of colorectal cancer.
PMID: 22294766
Ref: Diallyl sulfide, diallyl disulfide and diallyl trisulfide affect drug resistant gene expression in colo 205 human colon cancer cells in vitro and in vivo.
PMID: 22397993
Ref: Can immunohistochemistry of multidrug-resistant proteins replace the histoculture drug response assay in colorectal adenocarcinomas?
PMID: 22580657
Ref: Increased JNK1 signaling pathway is responsible for ABCG2-mediated multidrug resistance in human colon cancer.
PMID: 22870247
Ref: A prospective validation pharmacogenomic study in the adjuvant setting of colorectal cancer patients treated with the 5-fluorouracil/leucovorin/oxaliplatin (FOLFOX4) regimen.
PMID: 22868256
Ref: Role of conventional chemosensitivity test and tissue biomarker expression in predicting response to treatment of peritoneal carcinomatosis from colon cancer.
PMID: 23332421
Ref: Omega 3 fatty acids chemosensitize multidrug resistant colon cancer cells by down-regulating cholesterol synthesis and altering detergent resistant membranes composition.
PMID: 24225025
Ref: Galectin-3 silencing inhibits epirubicin-induced ATP binding cassette transporters and activates the mitochondrial apoptosis pathway via beta-catenin/GSK-3beta modulation in colorectal carcinoma.
PMID: 24303084
Ref: Synchronous rectal and gastric cancer in a fighter pilot: aeromedical concerns.
PMID: 24426647
Ref: Correlation of Nrf2, NQO1, MRP1, cmyc and p53 in colorectal cancer and their relationships to clinicopathologic features and survival.
PMID: 24695690
Ref: Selective cellular uptake and retention of SN 28049, a new DNA-binding topoisomerase II-directed antitumor agent.
PMID: 24801172
Ref: Liposomal nitrooxy-doxorubicin: one step over caelyx in drug-resistant human cancer cells.
PMID: 25057799
Ref: Genetic markers for toxicity of adjuvant oxaliplatin and fluoropyrimidines in the phase III TOSCA trial in high-risk colon cancer patients.
PMID: 25370899
Ref: [Function of death associated protein kinase(DAPK) in colorectal cancer chemoresistance].
PMID: 25421769
Ref: Knockdown of Akt2 expression by shRNA inhibits proliferation, enhances apoptosis, and increases chemosensitivity to paclitaxel in human colorectal cancer cells.
PMID: 25134663
Ref: Decreased functional activity of multidrug resistance protein in primary colorectal cancer.
PMID: 25885226
Ref: Hypoxia-inducible factor-1alpha induces multidrug resistance protein in colon cancer.
PMID: 26251616
Ref: Histone deacetylase 2 regulates doxorubicin (Dox) sensitivity of colorectal cancer cells by targeting ABCB1 transcription.
PMID: 26846508
Ref: The hypoxia-mimetic agent CoCl(2) induces chemotherapy resistance in LOVO colorectal cancer cells.
PMID: 26846577
Ref: miR-139-5p sensitizes colorectal cancer cells to 5-fluorouracil by targeting NOTCH-1.
PMID: 27173050
Ref: Drug membrane transporters and CYP3A4 are affected by hypericin, hyperforin or aristoforin in colon adenocarcinoma cells.
PMID: 27261575
Ref: Butyrate-mediated acquisition of chemoresistance by human colon cancer cells.
PMID: 27277338
Ref: SYNTHESIS AND CYTOTOXIC ACTIVITY OF NEW 5H-INDOLO[2,3-B]QUINOLINE O-AMINOGLYCOSIDES.
PMID: 27476287
Ref: Decellularized matrices as in vitro models of extracellular matrix in tumor tissues at different malignant levels: Mechanism of 5-fluorouracil resistance in colorectal tumor cells.
PMID: 27558478
Ref: Synergistic anticancer effect of exogenous wild-type p53 gene combined with 5-FU in human colon cancer resistant to 5-FU in vivo.
PMID: 27621580
Ref: Wnt-beta-catenin signaling regulates ABCC3 (MRP3) transporter expression in colorectal cancer.
PMID: 27709738
Ref: Molecular features of doxorubicin-resistance development in colorectal cancer CX-1 cell line.
PMID: 27746118
Ref: 2-Deoxy-D-glucose suppresses the migration and reverses the drug resistance of colon cancer cells through ADAM expression regulation.
PMID: 28059830
Ref: The role of MRP1 in the multidrug resistance of colorectal cancer.
PMID: 28454422
Ref: [MiR-145 inhibits drug resistance to Oxaliplatin in colorectal cancer cells through regulating G protein coupled receptor 98].
PMID: 28534337
Ref: Aldose reductase inhibitor increases doxorubicin-sensitivity of colon cancer cells and decreases cardiotoxicity.
PMID: 28600556
Ref: Twist1 confers multidrug resistance in colon cancer through upregulation of ATP-binding cassette transporters.
PMID: 28881781
Ref: miR-133b down-regulates ABCC1 and enhances the sensitivity of CRC to anti-tumor drugs.
PMID: 28881788
Ref: HES1 Promotes Colorectal Cancer Cell Resistance To 5-Fu by Inducing Of EMT and ABC Transporter Proteins.
PMID: 28928869
Ref: Modulation of the mRNA-binding protein HuR as a novel reversal mechanism of epirubicin-triggered multidrug resistance in colorectal cancer cells.
PMID: 28968471
Ref: The reversal effect of Ginsenoside Rh2 on drug resistance in human colorectal carcinoma cells and its mechanism.
PMID: 29582366
Ref: Effects of increased accumulation of doxorubicin due to emodin on efflux transporter and LRP1 expression in lung adenocarcinoma and colorectal carcinoma cells.
PMID: 29644529
Ref: IL-8 regulates the doxorubicin resistance of colorectal cancer cells via modulation of multidrug resistance 1 (MDR1).
PMID: 29693201
Ref: KDM5c inhibits multidrug resistance of colon cancer cell line by down-regulating ABCC1.
PMID: 30257334
Ref: ANRIL promotes chemoresistance via disturbing expression of ABCC1 by regulating the expression of Let-7a in colorectal cancer.
PMID: 30279206